|
|
【TMCLIFE 0101 交流专区】TMC生命科学
[复制链接]
|
|
|
发表于 25-6-2015 02:41 AM
|
显示全部楼层
Name | SASTERIA (M) PTE. LTD. | Address | 101 Thomson Road
#14-02/03 United Square
307591
Singapore. | NRIC/Passport No/Company No. | 201421357N | Nationality/Country of incorporation | Singapore | Descriptions (Class & nominal value) | Ordinary share of RM0.10 each | Name & address of registered holder | UOB Kay Hian Nominees (Asing) Sdn. Bhd.Level 8, Symphony HousePusat Dagangan Dana 1Jalan PJU 1A/4647301 Petaling JayaSelangor Darul Ehsan |
Details of changesCurrency: Malaysian Ringgit (MYR) | Type of transaction | Date of change | No of securities
| Price Transacted (RM)
| | Acquired | 23 Jun 2015 | 80,333,333
|
|
Circumstances by reason of which change has occurred | Nominee of alloted shares pursuant to the completion of the sale and purchase agreement entered into between Best Blend Sdn Bhd and TMC Life Sciences Berhad. | Nature of interest | Direct interest | Direct (units) | 901,638,155 | Direct (%) | 52.032 | Indirect/deemed interest (units) |
| | Indirect/deemed interest (%) |
| | Total no of securities after change | 901,638,155 | Date of notice | 24 Jun 2015 |
|
|
|
|
|
|
|
|
|
|
|
|
发表于 26-6-2015 03:58 AM
|
显示全部楼层
|
Notice of Interest Sub. S-hldr (29A) Amended Announcements
Please refer to the earlier announcement reference number: CS1-24062015-00003 Particulars of Substantial Securities HolderName | INCANTO INVESTMENTS LIMITED | Address | Suite 2803, 28/F
One Exchange Square
8 Connaught Place, Central
Hong Kong. | NRIC/Passport No/Company No. | 1608467 | Nationality/Country of incorporation | Virgin Islands, British | Descriptions (Class & nominal value) | Ordinary Shares of RM0.10 each | Name & address of registered holder | UOB Kay Hian Nominees (Asing) Sdn. Bhd.Level 8, Symphony HousePusat Dagangan Dana 1Jalan PJU 1A/4647301 Petaling JayaSelangor Darul EhsanBest Blend Sdn. Bhd.157A, Jalan Sri PelangiTaman Pelangi80400 Johor Bahru, Johor |
| Date interest acquired & no of securities acquired | Currency | Malaysian Ringgit (MYR) | Date interest acquired | 23 Jun 2015 | No of securities | 320,000,000 | Circumstances by reason of which Securities Holder has interest | Allotment of shares pursuant to the completion of the sale and purchase agreement entered into between Best Blend Sdn. Bhd. and TMC Life Sciences Berhad | Nature of interest | Direct and IndirectIndirect-Pursuant to Section 6A of the Companies Act, 1965, Incanto Investments Limited is deemed interested through its shareholding in Best Blend Sdn. Bhd. | Price Transacted ($$) |
|
| | Total no of securities after change | Direct (units) | 230,000,000 | Direct (%) | 13.273 | Indirect/deemed interest (units) | 90,000,000 | Indirect/deemed interest (%) | 5.194 | Date of notice | 24 Jun 2015 |
|
|
|
|
|
|
|
|
|
|
|
|
发表于 7-7-2015 06:41 PM
|
显示全部楼层
本帖最后由 icy97 于 8-7-2015 04:10 AM 编辑
柔州王儲入股TMC
財經企業7 Jul 2015 23:00
http://www.chinapress.com.my/node/636130
（吉隆坡7日訊）柔州王儲東姑依斯邁入股TMC（TMCLIFE，0101，主要板貿服），以7.67%股權成為新晉主要股東，至于新加坡大亨林榮福持有70.5%主要股權。
該公司向馬證交所報備，東姑依斯邁在脫售間接持有BB Waterfront私人有限公司30%股權后，獲得TMC發出的1億3300萬股新股。
TMC是通過發行價值4億令吉新股方式收購Best Blend私人有限公司旗下BB Waterfront股權。柔佛皇室持有Best Blend 30%股權，至于林榮福持有其余70%股權。
BB Waterfront持有新山康生依斯干達（Thomson Iskandar）醫療中心，將設有一家Iskandariah醫院。
Johor crown prince a substantial shareholder in TMC Life Sciences
By Chester Tay / theedgemarkets.com | July 7, 2015 : 6:25 PM MYT
http://www.theedgemarkets.com/my/article/johor-crown-prince-substantial-shareholder-tmc-life-sciences
KUALA LUMPUR (July 7): The Johor crown prince Tunku Ismail Ibni Sultan Ibrahim has emerged as a substantial shareholder holding a 7.67% stake in TMC Life Sciences Bhd, in which Singaporean tycoon Peter controls a 70.5% stake.
The filing to Bursa Malaysia shows that Tunku Ismail was issued the 133 million TMC Life shares after he sold an indirect 30% stake in BB Waterfront Sdn Bhd.
TMC took over the entire stake in BB Waterfront, a wholly-owned unit of Best Blend Sdn Bhd, for RM400 million by issue of shares. The Johor royalty held a 30% stake and Lim owned the remaining 70% in Best Blend.
BB Waterfront owns Thomson Iskandar, a medical hub project located on 1.6ha in Stulang Laut, which is within 1km radius of the Malaysian CIQ complex located at the Causeway linking Singapore to Johor Bahru.
The medical hub will contain a hospital named “Iskandariah Hospital”. Co-located with the hospital is an outpatient medical centre that will contain 400 clinic suites.
The medical hub will be managed by Thomson International, a subsidiary of Thomson Medical Pte Ltd — a private hospital owner and operator in Singapore
TMC Life (fundamental: 1.45; valuation: 0.9) closed half sen or 0.88% lower at 56 sen today, giving it a market capitalisation of RM979.06 million.
Notice of Interest Sub. S-hldr (29A)Particulars of Substantial Securities HolderName | DYAM TUNKU ISMAIL IBNI SULTAN IBRAHIM | Address | Istana Pasir Pelangi
Johor Bahru
80500 Johor
Malaysia. | NRIC/Passport No/Company No. | 840630015197 | Nationality/Country of incorporation | Malaysia | Descriptions (Class & nominal value) | Ordinary shares of RM0.10 each | Name & address of registered holder | DYAM Tunku Ismail Ibni Sultan IbrahimIstana Pasir Pelangi80500 Johor Bahru |
| Date interest acquired & no of securities acquired | Currency |
| | Date interest acquired | 23 Jun 2015 | No of securities | 133,000,000 | Circumstances by reason of which Securities Holder has interest | Allotment of shares pursuant to the completion of the sale and purchase agreement entered into between Best Blend Sdn. Bhd. and TMC Life Sciences Berhad. | Nature of interest | Direct interest | Price Transacted ($$) |
|
| | Total no of securities after change | Direct (units) | 133,000,000 | Direct (%) | 7.675 | Indirect/deemed interest (units) | 0 | Indirect/deemed interest (%) |
| | Date of notice | 29 Jun 2015 |
|
|
|
|
|
|
|
|
|
|
|
|
发表于 21-7-2015 11:50 PM
|
显示全部楼层
Date of change | 21 Jul 2015 | Name | MR JAMES OOI SIEW LOONG | Age | 48 | Nationality | Malaysia | Type of change | Resignation | Designation | Chief Financial Officer | Reason | Health reason |
|
|
|
|
|
|
|
|
|
|
|
|
发表于 25-7-2015 03:36 AM
|
显示全部楼层
Type | Announcement | Subject | OTHERS | Description | PROPOSED FINAL DIVIDEND | The Board of Directors of TMC Life Sciences Berhad is pleased to propose a single-tier final dividend of 1.4% for the financial year ended 31 May 2015 to the shareholders for approval at the forthcoming annual general meeting.
The entitlement and payment dates of the aforesaid dividend will be announced at a later date. |
|
|
|
|
|
|
|
|
|
|
|
|
发表于 25-7-2015 03:38 AM
|
显示全部楼层
本帖最后由 icy97 于 25-7-2015 08:54 PM 编辑
TMC生命科学 末季净利扬48.5%
二零一五年七月二十五日 晚上七时二十三分
（吉隆坡25日讯）由新加坡亿万富豪林荣福控有70.499%的TMC生命科学有限公司（TMCLIFE，0101，创业板），在2015财政年末季净利扬升48.5%。
截至5月31日止的2015财年末季，净利达398万令吉，或每股0.4仙，高于上财年同期的268万令吉，或每股0.33仙，归功于营业额走高。
末季营业额从前期的2375万令吉，增20%至2850万令吉。
该集团于致给大马交易所的声明中披露，2015财年的净利增53.6%至992万令吉，或每股1.01仙，同期为646万令吉，或每股0.8仙，由高营业额和利息收入推动。
全年营业额从同期的8649万令吉，增19.3%至1亿319万令吉。
TMC生命科学将末季营业额走高归因于病人人数增加，因为早前病床增加和增聘顾问。
不过，250万令吉的单次企业活动费用，以及聘请经验丰富的医疗保健专业人士而带来的员工成本，使2015财年的营运开支增加。
该集团指出，2016财年预计将增长，因计划扩大服务，以及大马医疗保健领域的增长前景依然乐观。
“本集团将继续通过吸引医疗、护理和专职医疗人才，扩大服务范围。”
然而，成本上涨仍是一个问题。
“大马经济似乎有所放缓。我们许多用品和药物均为进口产品，令吉走弱将不利于这些成本。”
此外，私人医院营运商必须小心处理消费税事项。【光华日报财经】
SUMMARY OF KEY FINANCIAL INFORMATION
31 May 2015 |
| | INDIVIDUAL PERIOD | CUMULATIVE PERIOD | CURRENT YEAR QUARTER | PRECEDING YEAR
CORRESPONDING
QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR
CORRESPONDING
PERIOD | 31 May 2015 | 31 May 2014 | 31 May 2015 | 31 May 2014 | $$'000 | $$'000 | $$'000 | $$'000 |
| 1 | Revenue | 28,501 | 23,752 | 103,185 | 86,494 | | 2 | Profit/(loss) before tax | 2,637 | 2,803 | 8,598 | 6,740 | | 3 | Profit/(loss) for the period | 3,982 | 2,681 | 9,923 | 6,457 | | 4 | Profit/(loss) attributable to ordinary equity holders of the parent | 3,982 | 2,681 | 9,923 | 6,457 | | 5 | Basic earnings/(loss) per share (Subunit) | 0.40 | 0.33 | 1.01 | 0.80 | | 6 | Proposed/Declared dividend per share (Subunit) | 0.14 | 0.30 | 0.14 | 0.30 |
|
| AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | 7
| Net assets per share attributable to ordinary equity holders of the parent ($$) | 0.3100 | 0.1700
|
|
|
|
|
|
|
|
|
|
|
|
|
发表于 4-8-2015 04:14 AM
|
显示全部楼层
Date of change | 03 Aug 2015 | Name | MR WONG YU CHEE | Age | 42 | Nationality | Malaysia | Type of change | Appointment | Designation | Chief Financial Officer | Qualifications | Fellow member of Association of Chartered Certified Accountants (FCCA)Member of Malaysian Institute of Accountants (MIA) - Chartered Accountant | Working experience and occupation | Mr. Wong has over 19 years of experience in finance, audit, accounting and tax compliance services in Malaysia and Shanghai. Prior to joining the Company, he worked in PCA Corporate Services Sdn. Bhd. as Group Chief Operating Officer. He was the Director of Accounting Services in TMF Malaysia between 2011 and 2015 after he worked in TMF Shanghai between 2008 and 2010. He has also worked in audit firms including Big 4 firms in Ernst & Young Shanghai and PricewaterhouseCoopers Malaysia between 1996 and 2008 before joining GlaxoSmithKline Consumer Healthcare Sdn Bhd as Finance Manager in 2008. |
|
|
|
|
|
|
|
|
|
|
|
|
发表于 1-9-2015 09:49 PM
|
显示全部楼层
本帖最后由 icy97 于 1-9-2015 09:51 PM 编辑
Date of change | 01 Sep 2015 | Name | DR WONG CHIANG YIN | Age | 47 | Nationality | Singapore | Type of change | Redesignation | Previous Position | Executive Director | New Position | Non Executive Director | Directorate | Non Independent and Non Executive |
Date of change | 02 Sep 2015 | Name | MR ROY QUEK HONG SHENG | Age | 45 | Nationality | Singapore | Designation | Chief Executive Officer | Directorate | Executive | Type of change | Others | Description | Mr. Roy Quek Hong Sheng has been appointed as Group Chief Executive Officer in addition to his role as Executive Director. |
|
|
|
|
|
|
|
|
|
|
|
|
发表于 26-9-2015 05:40 AM
|
显示全部楼层
EX-date | 26 Oct 2015 | Entitlement date | 28 Oct 2015 | Entitlement time | 05:00 PM | Entitlement subject | Final Dividend | Entitlement description | Final single tier dividend of 0.14 sen per ordinary share in respect of the financial year ended 31 May 2015. | Period of interest payment | to | Financial Year End | 31 May 2015 | Share transfer book & register of members will be | to closed from (both dates inclusive) for the purpose of determining the entitlement | Registrar or Service Provider name, address, telephone no | TRICOR INVESTOR SERVICES SDN BHDUnit 32-01, Level 32, Tower A, Vertical Business SuiteAvenue 3, Bangsar SouthNo. 8, Jalan Kerinchi59200 Kuala LumpurTel:0327839299Fax:0327839222 | Payment date | 09 Nov 2015 | a.Securities transferred into the Depositor's Securities Account before 4:00 pm in respect of transfers | 28 Oct 2015 | b.Securities deposited into the Depositor's Securities Account before 12:30 pm in respect of securities exempted from mandatory deposit |
| | c. Securities bought on the Exchange on a cum entitlement basis according to the Rules of the Exchange. | Number of new shares/securities issued (units) (If applicable) |
| | Entitlement indicator | Currency | Currency | Malaysian Ringgit (MYR) | Entitlement in Currency | 0.0014 | Par Value | Malaysian Ringgit (MYR) 0.100 |
|
|
|
|
|
|
|
|
|
|
|
|
发表于 2-10-2015 01:43 AM
|
显示全部楼层
Change in Financial Year End
Old financial year end | 31 May 2016 | New financial year end | 31 Aug 2016 |
|
|
|
|
|
|
|
|
|
|
|
|
发表于 22-10-2015 01:37 AM
|
显示全部楼层
SUMMARY OF KEY FINANCIAL INFORMATION
31 Aug 2015 |
| | INDIVIDUAL PERIOD | CUMULATIVE PERIOD | CURRENT YEAR QUARTER | PRECEDING YEAR
CORRESPONDING
QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR
CORRESPONDING
PERIOD | Three Months | Three Months | Three Months | Three Months | 01 Jun 2015
To | 01 Jun 2014
To | 01 Jun 2015
To | 01 Jun 2014
To | 31 Aug 2015 | 31 Aug 2014 | 31 Aug 2015 | 31 Aug 2014 | $$'000 | $$'000 | $$'000 | $$'000 |
| 1 | Revenue | 30,074 | 23,172 | 30,074 | 23,172 | | 2 | Profit/(loss) before tax | 4,350 | 643 | 4,350 | 643 | | 3 | Profit/(loss) for the period | 2,894 | 728 | 2,894 | 728 | | 4 | Profit/(loss) attributable to ordinary equity holders of the parent | 2,894 | 728 | 2,894 | 728 | | 5 | Basic earnings/(loss) per share (Subunit) | 0.24 | 0.09 | 0.24 | 0.09 | | 6 | Proposed/Declared dividend per share (Subunit) | 0.00 | 0.00 | 0.00 | 0.00 |
|
| AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | 7
| Net assets per share attributable to ordinary equity holders of the parent ($$) | 0.3600 | 0.2500
|
|
|
|
|
|
|
|
|
|
|
|
|
发表于 22-10-2015 04:35 PM
|
显示全部楼层
本帖最后由 icy97 于 24-10-2015 02:19 AM 编辑
冀与姐妹公司合作 TMC增医疗旅游收入
23/10/201521:22
（八打灵再也23日讯）医院经营商TMC生命科学有限公司（TMCLIFE，0101，创业板）或将与新加坡姐妹公司康生医院（Thomson Medical Centre Ltd）合作，以扩展大马业务。
TMC生命科学总执行长郭丰盛表示，该集团可能与康生医院寻求协同效应，然而不肯透露更多，仅说这是集团为了拓展业务的其中一个选项。
新加坡亿万富翁林荣福是TMC生命科学与康生医院共同大股东，持TMC生命科学70.5%。
由于TMC生命科学重视旗下医疗旅游业务，因此两家集团的协同作用是相当重要，以拓展TMC生命科学的区域地位。
他说，TMC生命科学的目标是医疗旅游的营业额贡献比重在5年内占25%。他不愿透露目前的贡献，仅说数额仍很小。
他指出，大马一年吸引80万医疗旅游的游客，且预料将会持续增长。
为了迎合这股需求，TMC生命科学正在扩展旗下位于雪州哥打白沙罗的丽阳医疗中心。该集团也在柔佛兴建一家名为Iskandariah Hospital的新医院。
“完成扩展计划后，丽阳医疗中心的床位将从原本的200张，增至600张。Iskandariah Hospital则能够提供500张床位的服务，可迎合来自本地与区域的需求，尤其是来自新加坡和印尼。”
“作为一家医疗服务业者，我们必须先把品牌建立好，并提供可信赖的服务，以吸引更多的医疗游客。”【光华日报财经】 |
|
|
|
|
|
|
|
|
|
|
|
发表于 23-1-2016 05:12 AM
|
显示全部楼层
本帖最后由 icy97 于 24-1-2016 04:52 PM 编辑
TMC 净利增45%
财经新闻 财经 2016-01-24 11:23
（吉隆坡23日讯）TMC生命科学（TMCLIFE，0101，主板贸服股）截至11月30日单季净利，按年增长44.69%，因营业额和利息收入增加。
公司净赚333万8000令吉，或每股净利0.24仙，高于上财年同季的230万7000令吉或0.28仙。
此外，营业额则增按年增长24.82%，达3133万2000令吉。
累计6个月业绩，净利按年飙涨105.34%，达623万2000令吉，或每股0.44仙；营业额按年上扬27.21%，达6140万6000令吉。
该公司将财政年截止日期，更改至8月31日。
因此，现财年将从2015年6月1日开始，直到2016年8月31日。【南洋网财经】
SUMMARY OF KEY FINANCIAL INFORMATION
30 Nov 2015 |
| | INDIVIDUAL PERIOD | CUMULATIVE PERIOD | CURRENT YEAR QUARTER | PRECEDING YEAR
CORRESPONDING
QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR
CORRESPONDING
PERIOD | Three Months | Three Months | Six Months | Six Months | 01 Sep 2015
To | 01 Sep 2014
To | 01 Jun 2015
To | 01 Jun 2014
To | 30 Nov 2015 | 30 Nov 2014 | 30 Nov 2015 | 30 Nov 2014 | $$'000 | $$'000 | $$'000 | $$'000 |
| 1 | Revenue | 31,332 | 25,101 | 61,406 | 48,273 | | 2 | Profit/(loss) before tax | 4,883 | 2,121 | 9,233 | 2,765 | | 3 | Profit/(loss) for the period | 3,338 | 2,307 | 6,232 | 3,035 | | 4 | Profit/(loss) attributable to ordinary equity holders of the parent | 3,338 | 2,307 | 6,232 | 3,035 | | 5 | Basic earnings/(loss) per share (Subunit) | 0.24 | 0.28 | 0.44 | 0.37 | | 6 | Proposed/Declared dividend per share (Subunit) | 0.00 | 0.00 | 0.00 | 0.00 |
|
| AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | 7
| Net assets per share attributable to ordinary equity holders of the parent ($$) | 0.3600 | 0.2500
|
|
|
|
|
|
|
|
|
|
|
|
|
发表于 19-3-2016 04:56 AM
|
显示全部楼层
Type | Announcement | Subject | OTHERS | Description | Incorporation of a wholly-owned subsidiary | The Board of Directors of TMC Life Sciences Berhad ("Company") is pleased to announce the incorporation of a wholly-owned subsidiary namely, TMC Care Sdn. Bhd. (“TMC Care”) on 18 March 2016.
The authorised share capital of TMC Care is RM400,000 divided into 400,000 ordinary shares of RM1.00 each with a total issued and paid-up share capital of RM1,000.00 comprising 1,000 ordinary shares of RM1.00 each.
The intended business activities of TMC Care are carrying on retail business of healthcare products.
The aforesaid incorporation would not have a material effect on the Group's earnings and net assets for the financial year ending 31 August 2016.
None of the Directors and substantial shareholders of the Company and persons connected to the Directors and substantial shareholders of the Company has any interest, direct or indirect, in the abovesaid matter. |
|
|
|
|
|
|
|
|
|
|
|
|
发表于 30-3-2016 01:08 AM
|
显示全部楼层
与英国伙伴洽商 TMC生科拟设医疗培训中心
财经新闻 财经 2016-03-29 07:38
（八打灵再也28日讯）TMC生命科学（TMCLIFE，0101，主板贸服股）正与英国培训机构洽谈，探讨在柔州成立医疗培训中心。
该公司总执行长郭鸿盛，今天在媒体汇报会上指出，公司目前正和潜在的英国伙伴洽谈，冀望在第三季能落实一些细节。
他指出，公司有意涉足医药培训，主要以通过所营运的医院，为客户提供综合医疗服务的策略。
冀进军印尼
此外，TMC生命科学有意在印尼巴厘岛投资发展医疗保健业务，提供先进和传统的医疗服务，因印尼政府计划推广医疗旅游。
郭鸿盛说，公司看好区域医疗保健领域未来的需求和发展，因此积极拓展业务版图，同时瞄准医疗旅游商机。”
他指出，公司在柔州新山兴建的Iskandariah医院，提供高素质的医疗服务设施和价格优惠，加上马新捷运系统（RTS），能吸引更多邻国的客户。
“该医院将兴建大型药剂店，放眼打造一站式医院，提供客户更大便利和广泛服务。”
郭鸿盛表示，Iskandariah医院有新加坡康生医院（Thomson Medical）作为策略合作伙伴，因此兴建的康生依斯干达（Thomson Iskandar），将是国内的第三个医疗枢纽。
他说，公司在中期锁定新加坡、大马和印尼“金三角”的客户，长期计划将范围扩大至中国、印度和澳洲。
积极拓展增床位
财务总监黄有志指出，现有董事部自2010年接手TMC生命科学后，经过重组和转型，成功将公司转盈，目前正处于快速增长轨道。
“公司在2015财年，将过去5年原有的60张床位，增至180张，目前正积极通过拓展计划增添床位。”
他透露，公司斥资3亿令吉，分2个阶段拓展位于雪州哥打白沙罗丽阳医院（TMC），在3年内将床位增至600张。
“另外，还有位于新山的Iskandariah医院，未来3年将建500张床位、400间医疗套房、提供有专业保健产品和服务零售店、护理及专职医疗培训中心的医院，耗资12亿令吉。”
他说，这2家医院的拓展计划，将在2019年竣工，迎合日益增长的需求。【南洋网财经】 |
|
|
|
|
|
|
|
|
|
|
|
发表于 22-4-2016 04:22 AM
|
显示全部楼层
本帖最后由 icy97 于 22-4-2016 03:36 PM 编辑
TMC 生科3个月赚328万
财
经新闻 财经 2016-04-22 10:51
（吉隆坡21日讯）营业额和利息收入增加，推动TMC生命科学（TMCLIFE，0101，主板贸服股）截至2月杪的3个月净利按年增12.7%，达327万5000令吉，或每股净利0.21仙。
营业额按年增长18.84%，达3138万6000令吉，主要因为病床量增加，促使病人人数增加、聘请新的咨询顾问，以及生殖业务取得较佳增长表现。
至于首九个月净利则按年提高60.02%，至950万7000令吉或每股净利0.61仙，而营业额则攀升24.25%，达9279万2000令吉。
此外，公司早前已宣布将财年截止日更换至8月31日，所以现财年期限从去年6月1日至今年8月31日。【南洋网财经】
SUMMARY OF KEY FINANCIAL INFORMATION
29 Feb 2016 |
| | INDIVIDUAL PERIOD | CUMULATIVE PERIOD | CURRENT YEAR QUARTER | PRECEDING YEAR
CORRESPONDING
QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR
CORRESPONDING
PERIOD | Three Months | Three Months | Nine Months | Nine Months | 01 Dec 2015
To | 01 Dec 2014
To | 01 Jun 2015
To | 01 Jun 2014
To | 29 Feb 2016 | 28 Feb 2015 | 29 Feb 2016 | 28 Feb 2015 | $$'000 | $$'000 | $$'000 | $$'000 |
| 1 | Revenue | 31,386 | 26,411 | 92,792 | 74,684 | | 2 | Profit/(loss) before tax | 4,854 | 3,196 | 14,087 | 5,961 | | 3 | Profit/(loss) for the period | 3,275 | 2,906 | 9,507 | 5,941 | | 4 | Profit/(loss) attributable to ordinary equity holders of the parent | 3,275 | 2,906 | 9,507 | 5,941 | | 5 | Basic earnings/(loss) per share (Subunit) | 0.21 | 0.32 | 0.61 | 0.65 | | 6 | Proposed/Declared dividend per share (Subunit) | 0.00 | 0.00 | 0.00 | 0.00 |
|
| AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | 7
| Net assets per share attributable to ordinary equity holders of the parent ($$) | 0.3600 | 0.2500
|
|
|
|
|
|
|
|
|
|
|
|
|
发表于 20-7-2016 04:00 AM
|
显示全部楼层
本帖最后由 icy97 于 21-7-2016 01:49 AM 编辑
TMC生科与狮城康生
探讨联营保健科学培训
2016年7月21日
（吉隆坡20日讯）TMC生命科学（TMCLIFE，0101，主板贸服股）与新加坡康生医院（Thomson Medical Centre），和爱尔兰都柏林大学学院签署了解备忘录，探讨联营保健科学培训和教育平台的可能。
该公司昨日向马交所报备，备忘录期限为1年，双方将共同研究在马新两国联营并成立保健科学训练和教育平台的可行性。
该公司指出，康生医院是新加坡领先的妇女和儿童保健服务机构之一。都柏林大学学院则是爱尔兰著名，以研究为主的大学，拥有超过160年历史。【e南洋】
Type | Announcement | Subject | MEMORANDUM OF UNDERSTANDING | Description | TMC LIFE SCIENCES BERHAD ("TMC" or "Company")Memorandum of Understanding entered between the Company, Thomson Medical Pte Ltd and University College Dublin | The Board of Directors of TMC Life Sciences Berhad wishes to announce that the Company has entered into a Memorandum of Understanding with Thomson Medical Pte Ltd and University College Dublin .
Please refer to the document attached for further details. |
http://www.bursamalaysia.com/market/listed-companies/company-announcements/5152069
|
|
|
|
|
|
|
|
|
|
|
|
发表于 21-7-2016 10:51 PM
|
显示全部楼层
Type | Announcement | Subject | MEMORANDUM OF UNDERSTANDING | Description | TMC LIFE SCIENCES BERHAD ("TMC" or "Company")Memorandum of Understanding entered between the Company and Cell Therapy Limited | The Board of Directors of TMC Life Sciences Berhad wishes to announce that the Company has entered into a Memorandum of Understanding with Cell Therapy
Limited.
Please refer to the document attached for further details. |
http://www.bursamalaysia.com/market/listed-companies/company-announcements/5152585
|
|
|
|
|
|
|
|
|
|
|
|
发表于 29-7-2016 02:21 AM
|
显示全部楼层
本帖最后由 icy97 于 29-7-2016 04:35 AM 编辑
病患人数增加推高TMC生命科学的净利
By Chester Tay / theedgemarkets.com | July 28, 2016 : 5:05 PM MYT
（吉隆坡28日讯）医院营运商TMC生命科学（TMC Life Sciences Bhd）截至2016年5月31日的财政年，净利按年增长35.31%至539万令吉，同期净赚398万令吉，归因于病患人数和病床增加、增聘顾问，以及生育业务和利息收入增长。
尽管如此，TMC生命科学的每股盈利则由此前的0.4仙，跌挫至0.32仙。
该集团向大马交易所报备，当季营业额则从上财年同期的2850万令吉，按年上扬22.49%至3491万令吉。
截至今年5月31日累计12个月的业绩表现，TMC生命科学的净利暴增50.11%至1490万令吉，同期净赚992万令吉；营业额扬23.76%至1亿2770万令吉，同期报1亿319万令吉；每股盈利则由1.01仙，滑落至0.88仙。
该集团在2015年10月1日宣布，将财年截止日更换至8月31日。
有鉴于此，TMC生命科学目前的财年截止日由原本的2015年6月1日，更换至2016年8月31日。
展望未来，TMC生命科学表示，由于人口结构的变化及社会更加富裕，加上人们更注重健康的生活方式，以及医疗旅游领域不断增长，大马医疗保健领域的增长前景依然正面。
不过，该集团也承认，汇率波动影响进口药品和医疗器材的供应。
“政府实施消费税（GST），以及人力成本与间接成本上涨，这些因素对我们的整体成本架构造成影响。”
随着两间新病房近期落成，TMC生命科学指出，其位于雪州哥打白沙罗的医院，目前一共有200张病床，以应付日益增长的需求。
“该集团在今年7月19日于新山开设TMC Care药房，同时也计划在今年9月于怡保增设一家TMC生育中心的分行。”
（编译：倪嫣鴽）
SUMMARY OF KEY FINANCIAL INFORMATION
31 May 2016 |
| | INDIVIDUAL PERIOD | CUMULATIVE PERIOD | CURRENT YEAR QUARTER | PRECEDING YEAR
CORRESPONDING
QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR
CORRESPONDING
PERIOD | Three Months | Three Months | Twelve Months | Twelve Months | 01 Mar 2016
To | 01 Mar 2015
To | 01 Jun 2015
To | 01 Jun 2014
To | 31 May 2016 | 31 May 2015 | 31 May 2016 | 31 May 2015 | $$'000 | $$'000 | $$'000 | $$'000 |
| 1 | Revenue | 34,910 | 28,501 | 127,702 | 103,185 | | 2 | Profit/(loss) before tax | 6,433 | 2,637 | 20,520 | 8,598 | | 3 | Profit/(loss) for the period | 5,388 | 3,982 | 14,895 | 9,923 | | 4 | Profit/(loss) attributable to ordinary equity holders of the parent | 5,388 | 3,982 | 14,895 | 9,923 | | 5 | Basic earnings/(loss) per share (Subunit) | 0.32 | 0.40 | 0.88 | 1.01 | | 6 | Proposed/Declared dividend per share (Subunit) | 0.00 | 0.14 | 0.00 | 0.14 |
|
| AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | 7
| Net assets per share attributable to ordinary equity holders of the parent ($$) | 0.3700 | 0.2500
|
|
|
|
|
|
|
|
|
|
|
|
|
发表于 12-8-2016 04:00 AM
|
显示全部楼层
Type | Announcement | Subject | OTHERS | Description | TMC LIFE SCIENCES BERHAD ("TMC" or "Company")Memorandum of Understanding entered between the Company and Advance Renal Care (Asia) Pte. Ltd. | The Board of Directors of TMC Life Sciences Berhad wishes to announce that the Company has entered into a Memorandum of Understanding ("MOU") with Advance Renal Care (Asia) Pte. Ltd.
Further details on the MOU and a copy of the press release in relation thereto are attached for information. |
http://www.bursamalaysia.com/market/listed-companies/company-announcements/5173245
|
|
|
|
|
|
|
|
|
|
| |
 本周最热论坛帖子
|
2134 
43
